Anna Protopapas - Director at Mersana Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
MRSN on Nasdaq
All Insider Reports
All Insider Reports

Anna Protopapas - trading volume in the past year for Mersana Therapeutics, Inc.

Holdings reported by Anna Protopapas for Mersana Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 125K $339K $2.71 Jan 16, 2024 Direct
Common Stock 72.3K $196K $2.71 Jan 13, 2024 By Trust
Stock Option (right to buy) 55K Jun 11, 2024 Direct Common Stock
Restricted Stock Unit 0 $2.71 Jan 15, 2024 Direct Common Stock

Transactions reported by Anna Protopapas for Mersana Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.